lysophosphatidic acid has been researched along with Hypertrophy in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Aidinis, V; Rai, V; Ray, R; Sinha, S | 1 |
Ding, W; Li, H; Liu, XY; Sun, W; Sun, XJ; You-Zhuan, X; Zhang, K; Zhao, CQ; Zhao, J | 1 |
Chen, C; Du, L; Han, C; Li, X; Qin, A; Zhang, K; Zhao, C; Zhao, J; Zhou, T | 1 |
Boyan, BD; Denison, TA; Hurst-Kennedy, J; Schwartz, Z | 1 |
Wei, L | 1 |
Cai, Y; Chen, J; Chen, X; Chen, Y; Cong, X; Deng, L; Han, B; Han, Y; Hu, S; Xu, R; Yang, Y; Zhu, W | 1 |
6 other study(ies) available for lysophosphatidic acid and Hypertrophy
Article | Year |
---|---|
Atx regulates skeletal muscle regeneration via LPAR1 and promotes hypertrophy.
Topics: Animals; Cell Line; Female; Gene Expression Regulation; Humans; Hypertrophy; Lysophospholipids; Male; Mice, Inbred C57BL; Mice, Knockout; Muscle Development; Muscle, Skeletal; Phosphoric Diester Hydrolases; Receptors, Lysophosphatidic Acid; Regeneration; Ribosomal Protein S6 Kinases; Satellite Cells, Skeletal Muscle; Signal Transduction; Skeletal Muscle Enlargement; TOR Serine-Threonine Kinases | 2021 |
Hypertrophy and Fibrosis of the Ligamentum Flavum in Lumbar Spinal Stenosis is Associated With Increased Expression of LPA and LPAR1.
Topics: Adult; Aged; Aged, 80 and over; Connective Tissue Growth Factor; Female; Fibrosis; Humans; Hypertrophy; Ligamentum Flavum; Lysophospholipids; Magnetic Resonance Imaging; Male; Middle Aged; Receptors, Lysophosphatidic Acid; Spinal Stenosis; Statistics as Topic; Young Adult | 2017 |
Lysophosphatidic Acid Induces Ligamentum Flavum Hypertrophy Through the LPAR1/Akt Pathway.
Topics: Animals; Apoptosis; Cell Proliferation; Cell Survival; Cells, Cultured; Cyclin-Dependent Kinases; G2 Phase Cell Cycle Checkpoints; Humans; Hypertrophy; Isoxazoles; Ligamentum Flavum; Lumbar Vertebrae; Lysophospholipids; Male; Phosphorylation; Propionates; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Receptors, Lysophosphatidic Acid; RNA Interference; Signal Transduction | 2018 |
24R,25-dihydroxyvitamin D3 [24R,25(OH)2D3] controls growth plate development by inhibiting apoptosis in the reserve zone and stimulating response to 1alpha,25(OH)2D3 in hypertrophic cells.
Topics: 24,25-Dihydroxyvitamin D 3; Animals; Apoptosis; Calcitriol; Caspase 3; Cell Proliferation; Chondrocytes; Enzyme Activation; Growth Plate; Hypertrophy; Lysophospholipids; Male; Phospholipases A2; Rats; Rats, Sprague-Dawley; Tumor Suppressor Protein p53 | 2010 |
Lysophospholipid signaling in cardiac myocyte hypertrophy.
Topics: Animals; GTP-Binding Protein alpha Subunits, Gq-G11; Humans; Hypertrophy; Lysophospholipids; Models, Biological; Myocardium; Myocytes, Cardiac; Receptors, G-Protein-Coupled; rho GTP-Binding Proteins; Signal Transduction | 2004 |
Specific LPA receptor subtype mediation of LPA-induced hypertrophy of cardiac myocytes and involvement of Akt and NFkappaB signal pathways.
Topics: Animals; Animals, Newborn; Cell Survival; Cells, Cultured; Diphosphates; Enzyme Inhibitors; Female; Glycerol; Hypertrophy; Lysophospholipids; MAP Kinase Signaling System; Myocardial Infarction; Myocytes, Cardiac; NF-kappa B; Organothiophosphates; Phosphatidic Acids; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Receptors, Lysophosphatidic Acid; Signal Transduction; Ventricular Function, Left; Ventricular Remodeling | 2008 |